Qube Research & Technologies Ltd

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,323,887

-$15,405,695 QoQ

Shares Held

116,363

-64.1% QoQ

Ownership

0.265%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#52

of 256 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. TARS ranks #57 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,323,887	116,363	-64.1%	Shares	Sole	2026-08-14
2026-03-31	$22,729,582	324,014	-19.2%	Shares	Sole	2026-05-15
2025-12-31	$32,853,613	401,241	-23.2%	Shares	Sole	2026-02-17
2025-09-30	$31,038,862	522,276	+13.7%	Shares	Sole	2025-11-14
2025-06-30	$18,611,752	459,436	+86.1%	Shares	Sole	2025-08-14
2025-03-31	$12,680,376	246,844	+151.9%	Shares	Sole	2025-05-15
2024-12-31	$5,426,038	97,996	+51.5%	Shares	Sole	2025-02-14
2024-09-30	$2,127,423	64,683	-71.5%	Shares	Sole	2024-11-14
2024-06-30	$6,166,571	226,879	+580.0%	Shares	Sole	2024-08-14
2024-03-31	$1,212,745	33,363	+472.5%	Shares	Sole	2024-05-14
2023-12-31	$118,017	5,828	-43.7%	Shares	Sole	2024-02-13
2023-03-31	$130,124	10,352	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.